CRISPR THERAPEUTICS AG

CRSP ·Healthcare, Drug Manufacturers - General
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2015

Total Assets: $159.4M

Liabilities Breakdown FY2015

Total Liabilities: $124.0M